Compare NetApp Inc. (NTAP) vs Teladoc Health Inc (TDOC) Price & Performance

NetApp (NTAP) trades at $237.15, up 0.56% today, with strong technical momentum as the stock approaches resistance near $239. The company demonstrates robust fundamentals with a 70.63% gross margin and consistent earnings beats, including Q2 2026 EPS of $2.58 beating expectations by 21.7%. Recent AI infrastructure partnerships with Oracle and Supermicro position NTAP for growth in enterprise data storage markets.

While valuation metrics appear elevated with a P/E of 32.63, the company's AI-driven growth strategy and strong profitability support upside potential. Key risks include competitive pressures in cloud storage and potential margin compression. Analyst consensus remains mixed with 38% buy ratings but a $219.30 price target below current levels, suggesting cautious optimism.

Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.

While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.